Skip to main content

tyrosine aminotransferase

The TAT gene provides instructions for making a liver enzyme called tyrosine aminotransferase. This enzyme is the first in a series of five enzymes that work to break down the amino acid tyrosine, a protein building block found in many foods. Specifically, tyrosine aminotransferase converts tyrosine into a byproduct called 4-hydroxyphenylpyruvate. Continuing the process, 4-hydroxyphenylpyruvate is further broken down and ultimately smaller molecules are produced that are either excreted by the kidneys or used to produce energy or make other substances in the body.

Video picks for Genes
Video library

Normal function

The TAT gene provides instructions for making a liver enzyme called tyrosine aminotransferase. This enzyme is the first in a series of five enzymes that work to break down the amino acid tyrosine, a protein building block found in many foods. Specifically, tyrosine aminotransferase converts tyrosine into a byproduct called 4-hydroxyphenylpyruvate. Continuing the process, 4-hydroxyphenylpyruvate is further broken down and ultimately smaller molecules are produced that are either excreted by the kidneys or used to produce energy or make other substances in the body.

Conditions referring to this gene or chromosome

Other names

ATTY_HUMAN

L-tyrosine:2-oxoglutarate aminotransferase

tyrosine transaminase

Related patient information and medicines

Mastocytosis and mast cell disorders

Patient information leaflet

Mastocytosis and mast cell disorders

If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (such as interferon), bone marrow transplant or... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Chronic myeloid leukaemia

Patient information leaflet

Chronic myeloid leukaemia

Treatment for the initial chronic phase The aim of treatment is to control the disease process, to ease any symptoms and to prevent (or delay) the progress... You may be advised to have one or more of the following treatments: Imatinib tablets. This medicine is known as a tyrosine kinase inhibitor. The chemical tyrosine kinase is made by the.

Mouth cancer

Patient information leaflet

Mouth cancer

Dia... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. To confirm the diagnosis It is likely that you will need a biopsy. Cetuximab is an.

Lapatinib tablets

Medicine leaflet

Lapatinib tablets

Lapatinib is given for the treatment of breast cancer. About lapatinib Type of medicine A tyrosine kinase inhibitor chemotherapy medicine Used for Treatment of breast cancer Also called Tyverb® Available as Tablets Lapatinib is a medicine which is given for the treatment of breast cancer Breast cancer which has progressed despite other treatment,.

Nilotinib capsules

Medicine leaflet

Nilotinib capsules

It is important that you keep the regular appointments with your doct... About nilotinib Type of medicine A tyrosine kinase inhibitor chemotherapy medicine Used for Treatment of chronic myeloid leukaemia Also called Tasigna® Available as Capsules Nilotinib is a medicine which is given to treat leukaemia Leukaemia. Leukaemia is cancer of cells in.

Erlotinib tablets

Medicine leaflet

Erlotinib tablets

Erlotinib is given for the treatment of lung cancer, or for the treatment of cancer of the pancreas. Contact your doctor straightaway if you de... About erlotinib Type of medicine A tyrosine kinase inhibitor chemotherapy medicine Used for Lung cancer, and cancer of the pancreas Also called Tarceva® Available as Tablets Erlotinib is a medicine.

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 Jan 2008 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.